1. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 (2017). https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm. Accessed 25 Aug 2021
2. Enhancing the Diversity of Clinical Trial Populations - Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry (2021). https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enhancing-diversity-clinical-trial-populations-eligibility-criteria-enrollment-practices-and-trial. Accessed 1 July 2021
3. Chen, Z., Liu, X., Hogan, W., Shenkman, E., Bian, J.: Applications of artificial intelligence in drug development using real-world data. Drug Discov. Today (2020)
4. Chen, Z., et al.: Exploring the feasibility of using real-world data from a large clinical data research network to simulate clinical trials of Alzheimer’s disease. NPJ Digit. Med. 4(1), 1–9 (2021)
5. Devlin, J., Chang, M.W., Lee, K., Toutanova, K.: BERT: pre-training of deep bidirectional transformers for language understanding. arXiv preprint arXiv:1810.04805 (2018)